category

Earnings Report

Drug firm AstraZeneca says 3Q earnings fall 12 percent.

Anglo-Swedish drugmaker AstraZeneca says third-quarter earnings fell 12 percent as its blockbuster cholesterol drug Crestor faced its first full quarter of competition in the United States from generic alternatives.

Mylan sees 3Q loss due to settlement for EpiPen overcharges

Drugmaker Mylan Inc. swung to a third-quarter loss, mainly due to a big settlement for overcharging the federal government for its controversial EpiPen, the emergency allergy injector whose price Mylan has repeatedly jacked up.

Mylan sees 3Q loss due to settlement for EpiPen overcharges

Drugmaker Mylan Inc. swung to a third-quarter loss, mainly due to a big settlement for overcharging the federal government for its controversial EpiPen, the emergency allergy injector whose price Mylan has repeatedly jacked up.

Shake Shack Stock Soars As Profit Doubles

Shake Shack Inc, known for indulgent antibiotic-free hamburgers, crinkle-cut fries and frozen custard shakes, on Wednesday said profits more than doubled, sending shares up 8.1 percent in extended trading.

Shake Shack Stock Soars As Profit Doubles

Shake Shack Inc, known for indulgent antibiotic-free hamburgers, crinkle-cut fries and frozen custard shakes, on Wednesday said profits more than doubled, sending shares up 8.1 percent in extended trading.

Viacom posts 4Q profit

Viacom Inc. (VIA) on Wednesday reported fiscal fourth-quarter earnings of $254 million.

Viacom posts 4Q profit

Viacom Inc. (VIA) on Wednesday reported fiscal fourth-quarter earnings of $254 million.

Viacom 4Q Revenue Falls 14.8%

Viacom reported a 14.8 percent fall in quarterly revenue, weighed down by lower domestic advertising revenue and an absence of hit movies.

Viacom 4Q Revenue Falls 14.8%

Viacom reported a 14.8 percent fall in quarterly revenue, weighed down by lower domestic advertising revenue and an absence of hit movies.